Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Shares Down 1.1% – Here’s What Happened

Posted by ABMN Staff on Jun 9th, 2026

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report)’s stock price traded down 1.1% during trading on Monday . The company traded as low as $28.75 and last traded at $28.77. 7,997 shares were traded during trading, a decline of 73% from the average session volume of 29,908 shares. The stock had previously closed at $29.09.

Invesco Nasdaq Biotechnology ETF Stock Performance

The stock has a market cap of $65.02 million, a PE ratio of 17.03 and a beta of 0.62. The company has a 50 day moving average of $29.34 and a two-hundred day moving average of $29.07.

Invesco Nasdaq Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 27th. Stockholders of record on Monday, March 23rd were given a $0.0361 dividend. The ex-dividend date was Monday, March 23rd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.5%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. WMS Group LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF in the 4th quarter valued at $4,255,000. LPL Financial LLC acquired a new position in Invesco Nasdaq Biotechnology ETF during the fourth quarter worth $1,220,000. Independent Advisor Alliance acquired a new position in Invesco Nasdaq Biotechnology ETF during the fourth quarter worth $653,000. GeoWealth Management LLC purchased a new position in Invesco Nasdaq Biotechnology ETF during the third quarter valued at $451,000. Finally, Orion Porfolio Solutions LLC purchased a new position in Invesco Nasdaq Biotechnology ETF during the fourth quarter valued at $392,000.

Invesco Nasdaq Biotechnology ETF Company Profile

(Get Free Report)

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.